82.56
前日終値:
$82.52
開ける:
$82.52
24時間の取引高:
452.29K
Relative Volume:
0.57
時価総額:
$4.54B
収益:
$1.43B
当期純損益:
$107.13M
株価収益率:
42.62
EPS:
1.9372
ネットキャッシュフロー:
$161.04M
1週間 パフォーマンス:
-1.27%
1か月 パフォーマンス:
+5.33%
6か月 パフォーマンス:
+28.18%
1年 パフォーマンス:
+76.90%
Livanova Plc Stock (LIVN) Company Profile
Compare LIVN vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
LIVN
Livanova Plc
|
82.56 | 4.54B | 1.43B | 107.13M | 161.04M | 1.9372 |
|
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-19 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2025-10-01 | ダウングレード | Goldman | Buy → Neutral |
| 2025-05-20 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2025-02-26 | ダウングレード | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 開始されました | Goldman | Buy |
| 2024-09-17 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 繰り返されました | Needham | Buy |
| 2024-02-20 | アップグレード | Mizuho | Neutral → Buy |
| 2023-09-06 | 開始されました | HSBC Securities | Hold |
| 2023-07-19 | 開始されました | Robert W. Baird | Neutral |
| 2023-04-14 | 開始されました | Mizuho | Neutral |
| 2022-12-21 | 開始されました | Barclays | Equal Weight |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-02-24 | アップグレード | UBS | Neutral → Buy |
| 2021-12-03 | 開始されました | Goldman | Buy |
| 2021-08-20 | 繰り返されました | Needham | Buy |
| 2021-07-20 | アップグレード | Needham | Hold → Buy |
| 2021-03-03 | ダウングレード | Berenberg | Buy → Hold |
| 2021-01-05 | ダウングレード | Needham | Buy → Hold |
| 2020-09-02 | 開始されました | Robert W. Baird | Outperform |
| 2020-06-26 | 繰り返されました | Needham | Buy |
| 2019-10-30 | 繰り返されました | Needham | Buy |
| 2019-02-28 | 繰り返されました | Needham | Buy |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-08-02 | 繰り返されました | Needham | Buy |
| 2018-06-08 | 開始されました | Stifel | Buy |
| 2018-05-31 | 繰り返されました | Needham | Buy |
| 2018-02-28 | 繰り返されました | Needham | Buy |
すべてを表示
Livanova Plc (LIVN) 最新ニュース
World Cardiopulmonary Bypass MachineMarket Analysis, Forecast, Size, Trends and Insights - IndexBox
Price to earnings forward of LivaNova Plc – SWB:LIA - TradingView
Price to sales forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC balances neuromodulation growth with cardiac surgery challenges - ad-hoc-news.de
(LIVN) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Enterprise value to EBITDA forward of LivaNova PLC – NASDAQ:LIVN - TradingView
LivaNova PLC (LIVN) Hit a 52 Week High, Can the Run Continue? - Yahoo Finance
LivaNova PLC focuses on neuromodulation and cardiopulmonary solutions as investors track its Nasdaq- - ad-hoc-news.de
Enterprise value to revenue forward of LivaNova PLC – NASDAQ:LIVN - TradingView
Price to sales forward of LivaNova Plc – LSX:A14156 - TradingView
Price to book forward of LivaNova PLC – NASDAQ:LIVN - TradingView
How LivaNova’s Broad Russell Index Inclusion Will Impact LivaNova (LIVN) Investors - simplywall.st
LivaNova stock hits 52-week high at 84.3 USD - Investing.com
LivaNova Plc Change Of Registered Office - marketscreener.com
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Sahm
Livanova stock initiated at Hold by Freedom Capital on growth outlook - Investing.com Nigeria
LivaNova Shares Positive 12-Month Results From Obstructive Sleep Apnea Study - Medical Product Outsourcing
LivaNova PLC(NasdaqGS: LIVN) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 2500 Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 2000 Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 3000E Growth Benchmark - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 2000 Growth-Defensive Index - marketscreener.com
LivaNova PLC(NasdaqGS: LIVN) added to Russell 3000 Growth Benchmark - marketscreener.com
(LIVN) Risk Channels and Responsive Allocation - Stock Traders Daily
LivaNova Plc Hits New 52-Week High of USD 82.62 - MarketsMojo
LivaNova PLC (LIVN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Brain Implants Market Size to Reach USD 18.39 Billion by 2035, Growing at 9.99% CAGR | SNS Insider - GlobeNewswire Inc.
Livanova PLC Shs Unsponsored Brazilian Depositary Receipt Repr 0.125 Sh - TradingView
LivaNova Plc Actuals & Estimates (NASDAQ:LIVN) - TradingView
LivaNova reports improved OSA outcomes with PolySync programming - MSN
LIVN Forecast — Price Target — Prediction for 2027 - TradingView
LIA Forecast — Price Target — Prediction for 2027 - TradingView
LivaNova stock hits 52-week high at 81.08 USD - Investing.com UK
LivaNova stock hits 52-week high at 81.08 USD By Investing.com - Investing.com Nigeria
How New OSA PolySync Data Could Shape LivaNova’s (LIVN) Neuromodulation Investment Narrative - Sahm
LivaNova to announce second-quarter 2026 results on Aug 5 - scanx.trade
Press Release: LivaNova to Announce Second-Quarter 2026 Results - Moomoo
Beyond the Balance Sheet: LivaNova's Q2 to Test Med-Tech's Pulse - BriefGlance
LivaNova demonstrates 84.5% cumulative response rate with PolySync programming in OSPREY study for obstructive sleep apnea - MSN
LIVN Maintained by Keybanc -- Price Target Raised to $92.00 - GuruFocus
LivaNova PLC (LIVN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LIVN SEC FilingsLivanova Plc 10-K, 10-Q, 8-K Forms - Stock Titan
Jette Nygaard-Andersen joins LivaNova board as a new director - MSN
LivaNova PLC (LIVN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LivaNova PLC (LIVN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LivaNova PLC (LIVN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LivaNova Plc Hits New 52-Week High of USD 80.77 - MarketsMojo
LivaNova PLC (LIVN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Livanova Plc (LIVN) 財務データ
収益
当期純利益
現金流量
EPS
Livanova Plc (LIVN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| SCHERMERHORN TODD C | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
13,105 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
11,270 |
| Bianchi Francesco | Director |
Jun 15 '26 |
Sale |
80.19 |
1,200 |
96,228 |
9,584 |
| PODLOGAR SUSAN M | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
6,128 |
| Barry James Christopher | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
8,404 |
| Tezel Ahmet | Chief Innovation Officer |
Jun 15 '26 |
Option Exercise |
0.00 |
2,965 |
0 |
7,122 |
| KOZY WILLIAM A | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
5,681 |
0 |
38,248 |
| Enxing Seng Stacy | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
15,793 |
| Story Brooke | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
4,042 |
0 |
10,274 |
| Zurbay Donald | Director |
Jun 15 '26 |
Option Exercise |
0.00 |
2,560 |
0 |
2,560 |
大文字化:
|
ボリューム (24 時間):